Medtronic Names Chad Spooner as CFO of MiniMed Diabetes Spinoff

Medtronic has appointed Chad Spooner as chief financial officer (CFO) of MiniMed in advance of its planned separation into a standalone, public company. Beginning July 14, Spooner will oversee the finance function for Medtronic Diabetes and support the company as it prepares to become fully independent.

Spooner was most recently CFO at BIC, a global consumer goods company. He began his career at General Electric, where he spent a decade in management positions of growing responsibility in corporate audit and financial planning, as well as a senior finance role in GE Energy.

He then served in CFO roles at Raffaela Apparel Group and Slingshot Health, and held senior operational finance roles at Tenex Capital Management, a middle-market private equity firm he co-founded with over $1 billion in investments.

“We’re excited to welcome Chad to the executive team at such a pivotal time for our business,” said Que Dallara, EVP and president of Medtronic Diabetes and CEO Designate of MiniMed. “Chad’s deep financial expertise, impressive track record, and proven leadership in driving transformation and growth will be instrumental as we prepare for our next chapter as an independent company. His appointment underscores our commitment to building a strong foundation for long-term success so we can continue to enhance the lives of individuals with diabetes we’re privileged to serve.”

Medtronic revealed MiniMed as the name for the company following the separation last month. The company expects to finish the separation within 18 months of the first announcement through a series of capital markets transactions.

“I’m excited for the opportunity to help shape the future of a company with such a meaningful Mission, and I look forward to working with Que and the leadership team to build a strong, agile finance organization that supports innovation, drives sustainable growth, and creates long-term value for all stakeholders,” said Spooner.